Strata Critical Medical, Inc.
Price Action
Technical Summary
WEAKENINGStrata Critical Medical, Inc. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is moderate (RS Rating: 62), indicating performance broadly in line with the market. Earnings growth of 175% provides fundamental context to the price action. Investors should exercise caution due to high volatility (64% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $5.73 | -9.59% | BELOW |
| 50 SMA | $5.49 | -5.69% | BELOW |
| 100 SMA | $4.95 | +4.58% | ABOVE |
| 150 SMA | $4.97 | +4.18% | ABOVE |
| 200 SMA | $4.98 | +4.04% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is SRTA in an uptrend right now?
SRTA has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.
Is SRTA overbought or oversold?
SRTA's RSI (14) is 41. The stock is in neutral territory, neither overbought nor oversold.
Is SRTA outperforming the market?
SRTA has a Relative Strength (RS) Rating of 62 out of 99. SRTA is performing about average compared to the market.
Where is SRTA in its 52-week range?
SRTA is trading at $5.18, which is 80% of its 52-week high ($6.50) and 53% above its 52-week low ($3.68).
How volatile is SRTA?
SRTA has a Beta of 2.30 and 52-week volatility of 64%. It's more volatile than the S&P 500 - expect bigger swings.